Jazz Pharmaceuticals JAZZ
$230.26 −$6.19 (-2.62%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $230.62 +0.16%
Open$235.19
Prev close$236.45
Day range$227.95 – $238.59
Volume984.7K
Market cap$14.78B
P/E (TTM)68.1
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.24B+10.4% YoY
Operating profit$340.80M+240.8% YoY
Net profit-$483.40M-292.3% YoY
Diluted EPS-$7.48-283.3% YoY
Free cash flow$489.90M+26.6% YoY
Operating cash flow$506.10M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin89.1%
Operating margin24.0%
Net margin4.4%
Return on equity5.1%
Return on assets1.8%
Return on invested capital3.5%
Current ratio1.82
Liabilities / assets65.1%
Cash & investments$2.86B
Total debt$5.63B
Net cash (debt)-$2.77B
Free cash flow / sales30.0%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.24B | $1.21B | $1.07B | $4.27B | $1.20B |
| Total Operating Revenue | $1.24B | $1.21B | $1.07B | $4.27B | $1.20B |
| Cost of Revenue | $110.60M | $116.40M | $134.10M | $503.30M | $153.50M |
| Gross Profit | $1.13B | $1.09B | $934.80M | $3.76B | $1.04B |
| Operating Expense | $791.60M | $766.70M | $721.00M | $3.25B | $789.97M |
| Selling and Admin Expenses | $407.90M | $389.20M | $352.70M | $1.81B | $406.27M |
| Research & Development | $211.90M | $207.50M | $196.00M | $782.74M | $213.94M |
| Depreciation & Amortization & Depletion | $171.80M | $170.00M | $172.30M | $654.66M | $169.76M |
| -Depreciation & Amortization | $171.80M | $170.00M | $172.30M | $654.66M | $169.76M |
| Operating Profit | $340.80M | $325.20M | $213.80M | $517.62M | $254.52M |
| Net Non-Operating Interest Income (Expense) | -$45.50M | -$37.10M | -$39.90M | -$195.05M | -$45.35M |
| Non-Operating Interest Expense | $45.50M | $37.10M | $39.90M | $195.05M | $45.35M |
| Other Income (Expense) | -$754.20M | -$77.10M | $125.30M | -$950.43M | -$630,000.00 |
| Special Income (Charges) | -$754.20M | -$77.00M | $122.80M | -$947.86M | $38,000.00 |
| -Less:Other Special Charges | $754.20M | $77.00M | – | $947.86M | -$38,000.00 |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | $0.00 | $122.80M | – | – |
| Pretax Profit | -$458.90M | $211.00M | $299.20M | -$627.86M | $208.54M |
| Tax | $24.50M | $18.10M | $6.10M | -$272.44M | $4.96M |
| $0.00 | $100,000.00 | $0.00 | $732,000.00 | $132,000.00 | |
| Net Profit | -$483.40M | $192.80M | $293.10M | -$356.15M | $203.45M |
| Profit from Continuing Operations | -$483.40M | $192.80M | $293.10M | -$356.15M | $203.45M |
| Net Income to Parent Company | -$483.40M | $192.80M | $293.10M | -$356.15M | $203.45M |
| Net Income to Common Stockholders | -$483.40M | $192.80M | $293.10M | -$356.15M | $203.45M |
| Basic EPS | -$7.48 | $3.05 | $4.73 | -$5.84 | $3.33 |
| Diluted EPS | -$7.48 | $2.78 | $4.43 | -$5.84 | $3.21 |
| Gain on Sale of Security | – | -$100,000.00 | $2.50M | -$2.57M | -$668,000.00 |
| Other Operating Expenses | – | – | -$122.80M | – | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $12.00B | $11.08B | $11.86B | $11.66B | $11.66B |
| Total Current Assets | $4.61B | $3.97B | $4.58B | $4.17B | $4.17B |
| Cash and Cash Equivalents & Short-Term Investments | $2.86B | $2.20B | $2.87B | $2.44B | $2.44B |
| -Cash and Cash Equivalents | $2.04B | $1.62B | $1.84B | $1.39B | $1.39B |
| -Short Term Investments | $820.00M | $580.00M | $1.03B | $1.05B | $1.05B |
| Receivables | $873.70M | $880.90M | $836.30M | $830.75M | $830.75M |
| -Accounts Receivable | $873.70M | $880.90M | $836.30M | $830.75M | $830.75M |
| Prepaid Assets | $170.90M | $200.00M | $149.70M | $152.48M | $152.48M |
| Inventory | $454.00M | $443.00M | $437.50M | $416.96M | $416.96M |
| Other Current Assets | $258.40M | $244.50M | $285.30M | $323.95M | $323.95M |
| Total Non-Current Assets | $7.38B | $7.11B | $7.28B | $7.49B | $7.49B |
| Net PPE | $292.00M | $264.10M | $258.90M | $258.74M | $258.74M |
| -Gross PPE | $488.00M | $454.60M | $440.60M | $437.29M | $437.29M |
| -Accumulated Depreciation | -$196.00M | -$190.50M | -$181.70M | -$178.55M | -$178.55M |
| Goodwill and Other Intangible Assets | $5.98B | $5.83B | $6.01B | $6.26B | $6.26B |
| -Goodwill | $1.80B | $1.80B | $1.81B | $1.83B | $1.83B |
| -Other Intangible Assets | $4.17B | $4.03B | $4.20B | $4.43B | $4.43B |
| Non-Current Deferred Assets | $1.00B | $933.00M | $914.10M | $876.68M | $876.68M |
| Other Non-Current Assets | $111.00M | $86.30M | $94.70M | $99.03M | $99.03M |
| Total Liabilities | $7.81B | $6.28B | $7.33B | $7.34B | $7.34B |
| Total Current Liabilities | $2.53B | $2.23B | $2.25B | $2.24B | $2.24B |
| Payables | $439.50M | $184.40M | $193.70M | $178.45M | $178.45M |
| -Accounts Payable | $380.30M | $128.50M | $100.00M | $122.06M | $122.06M |
| -Total Tax Payable | $59.20M | $55.90M | $93.70M | $56.39M | $56.39M |
| Current Accrued Expenses | $846.80M | $858.10M | $790.20M | $773.47M | $773.47M |
| Short-Term Debt and Capital Lease Obligation | $1.03B | $1.03B | $1.05B | $1.04B | $1.04B |
| -Current Debt | $1.02B | $1.02B | $1.03B | $1.03B | $1.03B |
| -Current Capital Lease Obligation | $14.90M | $14.30M | $14.90M | $14.72M | $14.72M |
| Current Provisions | $29.80M | $28.70M | $26.60M | $26.41M | $26.41M |
| Other Current Liabilities | $7.10M | $8.60M | $8.50M | $4.23M | $4.23M |
| Total Non-Current Liabilities | $5.27B | $4.05B | $5.08B | $5.10B | $5.10B |
| Long Term Debt and Capital Lease Obligation | $4.61B | $3.38B | $4.37B | $4.38B | $4.38B |
| -Long Term Debt | $4.55B | $3.34B | $4.32B | $4.33B | $4.33B |
| -Long Term Capital Lease Obligation | $60.70M | $43.60M | $47.30M | $50.89M | $50.89M |
| Non-Current Deferred Liabilities | $506.10M | $528.90M | $547.70M | $594.47M | $594.47M |
| Other Non-Current Liabilities | $153.80M | $140.90M | $161.50M | $124.52M | $124.52M |
| Total Equity | $4.19B | $4.80B | $4.53B | $4.32B | $4.32B |
| Stockholders' Equity | $4.19B | $4.80B | $4.53B | $4.32B | $4.32B |
| Capital Stock | $100,000.00 | $100,000.00 | $100,000.00 | $61,000.00 | $61,000.00 |
| -Common Stock | $100,000.00 | $100,000.00 | $100,000.00 | $61,000.00 | $61,000.00 |
| Additional Paid-In Capital | $4.41B | $4.33B | $4.24B | $4.24B | $4.24B |
| Retained Earnings | $423.60M | $1.13B | $939.20M | $646.18M | $646.18M |
| Gains/Losses Not Affecting Retained Earnings | -$646.60M | -$662.50M | -$651.00M | -$568.60M | -$568.60M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $506.10M | $415.70M | $408.20M | $1.36B | $362.47M |
| Net cash flow from continuing operations | $506.10M | $415.70M | $408.20M | $1.36B | $362.47M |
| Net Income from Continuing Operations | -$483.40M | $192.80M | $293.10M | -$356.15M | $203.45M |
| Depreciation & Depletion & Amortization | $178.90M | $179.10M | $181.40M | $696.30M | $179.20M |
| Deferred Tax | -$44.80M | -$38.70M | -$66.20M | -$444.97M | -$63.27M |
| Other Non-Cash Items | $636.40M | $218.90M | -$76.70M | $1.13B | $40.86M |
| Change in Working Capital | $12.70M | -$94.40M | -$12.10M | $18.90M | -$72.70M |
| -Change in Receivables | $6.80M | -$44.90M | -$6.50M | -$106.28M | -$65.78M |
| -Change in Inventory | -$15.60M | -$29.90M | -$77.80M | -$86.04M | $7.76M |
| -Change in Prepaid Assets | $19.30M | $4.90M | $51.90M | $29.03M | -$6.17M |
| -Change in Payables and Accrued Expense | -$9.50M | -$700,000.00 | $8.10M | $154.17M | -$37.53M |
| -Change in Other Current Liabilities | $11.70M | -$23.80M | $12.20M | $28.02M | $29.02M |
| Net cash flow from investing | -$1.08B | $354.90M | $123.10M | -$1.51B | -$372.11M |
| Net Cash Flow from Continuing Investing Activities | -$1.08B | $354.90M | $123.10M | -$1.51B | -$372.11M |
| Net PPE Purchase and Sale | -$16.20M | -$18.10M | -$19.70M | -$58.75M | -$16.75M |
| Net Intangibles Purchase and Sale | $0.00 | -$154.20M | $0.00 | -$151.00M | -$53.50M |
| Net Investment Purchase and Sale | -$240.00M | $250.00M | $220.00M | -$470.28M | -$330.08M |
| Net Other Investing Changes | -$827.60M | $277.20M | -$77.20M | $28.17M | $886.27M |
| Financing Cash Flow | $993.70M | -$994.50M | -$78.50M | -$873.38M | $75.42M |
| Net Cash Flow from Continuing Financing Activities | $993.70M | -$994.50M | -$78.50M | -$873.38M | $75.42M |
| Net Issuance Payments Of Debt | -$7.80M | -$1.01B | -$7.80M | -$781.00M | -$7.70M |
| Net Common Stock Issuance | -$225.00M | – | – | -$125.02M | -$23,000.00 |
| Proceeds from Stock Option Exercised | $10.60M | $22.70M | $32.90M | $107.86M | $85.16M |
| Net Other Financing Charges | $1.22B | -$9.50M | -$103.60M | -$75.22M | -$2.02M |
| Ending Cash Balance | $2.04B | $1.62B | $1.84B | $1.39B | $1.39B |
| Net Change in Cash | $416.00M | -$223.90M | $452.80M | -$1.03B | $65.78M |
| Beginning Cash Balance | $1.62B | $1.84B | $1.39B | $2.41B | $1.33B |
| Effect of Exchange Rate Changes | $600,000.00 | -$600,000.00 | -$400,000.00 | $6.56M | $55,000.00 |
| Free Cash Flow | $489.90M | $243.40M | $388.50M | $1.15B | $292.22M |
| Net Business Purchase and Sale | – | – | – | -$858.05M | – |
No comments yet — be the first to weigh in on JAZZ.
Sign in to join the discussion.